Flynn James E 13D and 13G filings for Rhythm Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 4:17 pm Sale | 2021-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | Flynn James E | 1,867,467 3.710% | -853,736 (-31.37%) | Filing |
| 2021-02-12 12:31 pm Sale | 2020-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | Flynn James E | 2,721,203 6.160% | -1,568,088 (-36.56%) | Filing |